Atg2B, a crucial protein in the autophagy pathway, plays a pivotal role in the regulation and formation of autophagosomes, essential for cellular homeostasis and the degradation of cytoplasmic components. This protein is integral to the elongation of the phagophore, a key step in the autophagy process, by facilitating the transfer of lipids to growing autophagosomes, thereby ensuring their expansion and maturation. The functional significance of Atg2B extends beyond mere participation in autophagy; it is also implicated in maintaining the integrity of cellular energy levels and nutrient availability, highlighting its importance in cellular physiology and stress response mechanisms. The ability of Atg2B to interface with various components of the autophagy machinery, including Atg9 vesicles and the phosphatidylinositol 3-phosphate (PI3P)-rich membranes, underscores its role as a linchpin in orchestrating the complex dynamics of autophagosome formation.
Inhibition of Atg2B disrupts the autophagic flux, leading to impaired autophagosome formation and a subsequent accumulation of damaged organelles and protein aggregates, which can have profound effects on cellular health and function. Mechanistically, the inhibition of Atg2B perturbs the lipid transfer between membranes, stalling the expansion of the phagophore and preventing the completion of the autophagosome. This interruption in the autophagy pathway can result from various factors, including alterations in protein-protein interactions, modifications in the protein's structure or expression levels, or disruptions in the lipid microenvironment essential for its activity. The precise regulation of Atg2B's activity is critical, as it ensures the timely formation of autophagosomes in response to cellular needs, facilitating the removal of cellular debris and the recycling of nutrients. Thus, understanding the mechanisms by which Atg2B is inhibited offers insights into the modulation of autophagy and its implications for cellular homeostasis, highlighting the protein's essential role in maintaining the balance between synthesis and degradation within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine (3-MA) inhibits autophagy by blocking autophagosome formation, potentially altering ATG2B activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K, which is involved in the initiation of autophagy, indirectly affecting ATG2B. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Spautin-1 promotes the degradation of certain autophagy-related proteins and could alter ATG2B function by disrupting the autophagic process. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Hydroxychloroquine disrupts autophagosome function by increasing lysosomal pH, which may indirectly impede ATG2B activity. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 specifically inhibits V-ATPase, preventing autophagosome-lysosome fusion, which indirectly impacts ATG2B. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
SAR405 is a PIK3C3/Vps34 inhibitor that can disrupt early stages of autophagosome formation affecting ATG2B's role. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor that can interrupt the autophagy signaling process, indirectly influencing ATG2B. | ||||||
PIK-III | 1383716-40-2 | sc-507530 | 5 mg | $170.00 | ||
PIK-III selectively inhibits Vps34, which is essential for autophagy initiation, potentially affecting ATG2B. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 202190 inhibits p38 MAPK, which can regulate autophagy under stress, possibly altering ATG2B function. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Concanamycin A is another V-ATPase inhibitor that prevents acidification of lysosomes, indirectly affecting ATG2B. | ||||||